Skip to content
10-Q

Quarterly Report

CTI BIOPHARMA CORP

0000891293-22-000054

← back to feed
Filed
Nov 7, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 126.89M sh
Shares Diluted Q3 2022 · Sep 30, 2022 121.6M sh
Shares Diluted Q3 2022 · Sep 30, 2022 110.07M sh
Shares Diluted Q3 2022 · Sep 30, 2021 93.82M sh
Shares Diluted Q3 2022 · Sep 30, 2021 87.57M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$65.68M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$54.87M
Long Term Debt Q3 2022 · Sep 30, 2022 $47.8M
Long Term Debt Q3 2022 · Dec 31, 2021 $0
Short Term Debt Q3 2022 · Sep 30, 2022 $0
Short Term Debt Q3 2022 · Dec 31, 2021 $47.38M
Short Term Investments Q3 2022 · Sep 30, 2022 $49.59M
Short Term Investments Q3 2022 · Dec 31, 2021 $0
Cash And Equivalents Q3 2022 · Sep 30, 2022 $32.05M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $65.45M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$16.84M
Stockholders Equity Q3 2022 · Dec 31, 2021 $3.77M
Current Liabilities Q3 2022 · Sep 30, 2022 $29.77M
Current Liabilities Q3 2022 · Dec 31, 2021 $66.65M
Total Liabilities Q3 2022 · Sep 30, 2022 $140.3M
Total Liabilities Q3 2022 · Dec 31, 2021 $68.67M
Current Assets Q3 2022 · Sep 30, 2022 $96.94M
Current Assets Q3 2022 · Dec 31, 2021 $68.38M
Total Assets Q3 2022 · Sep 30, 2022 $123.47M
Total Assets Q3 2022 · Dec 31, 2021 $72.43M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.13
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.69
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.26
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.70
Eps Basic Q3 2022 · Sep 30, 2022 −$0.13
Eps Basic Q3 2022 · Sep 30, 2022 −$0.69
Eps Basic Q3 2022 · Sep 30, 2021 −$0.26
Eps Basic Q3 2022 · Sep 30, 2021 −$0.70
Sga Expense Q3 2022 · Sep 30, 2022 $21.5M
Sga Expense Q3 2022 · Sep 30, 2022 $61.13M
Sga Expense Q3 2022 · Sep 30, 2021 $13.66M
Sga Expense Q3 2022 · Sep 30, 2021 $31.5M
Net Income Q3 2022 · Sep 30, 2022 −$15.71M
Net Income Q3 2022 · Sep 30, 2022 −$75.53M
Net Income Q3 2022 · Jun 30, 2022 −$22.65M
Net Income Q3 2022 · Mar 31, 2022 −$37.18M
Net Income Q3 2022 · Sep 30, 2021 −$24.18M
Net Income Q3 2022 · Sep 30, 2021 −$61.12M
Net Income Q3 2022 · Jun 30, 2021 −$19.68M
Net Income Q3 2022 · Mar 31, 2021 −$17.27M
Operating Income Q3 2022 · Sep 30, 2022 −$12.22M
Operating Income Q3 2022 · Sep 30, 2022 −$66.2M
Operating Income Q3 2022 · Sep 30, 2021 −$23.38M
Operating Income Q3 2022 · Sep 30, 2021 −$59.96M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $1.15M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $2.35M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2022 $18.24M
Revenue Q3 2022 · Sep 30, 2022 $32.87M
Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2021 $0